Thank you for subscribing!
Finfeed Archived Aug 12, 2020
Creso Pharma Limited (ASX: CPH; FRA: 1X8) has signed a commercial agreement with DHS Business Portugal to introduce the group’s products into the Portuguese and Spanish markets, effectively expanding the company’s presence in Europe.
Get expert stock analysis direct in your inbox
Join Our Mailing List